MARÍA DEL CARMEN GARCÍA MACÍAS-rekin lankidetzan egindako argitalpenak (1)

2017

  1. Correction: The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin [Oncotarget, 6, (2015), (18875-18890)]. doi: 10.18632/oncotarget.4303

    Oncotarget